Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension

@inproceedings{Galambos2016IncreasedLE,
  title={Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension},
  author={Csaba Galambos and Angela D. Minic and Douglas Bush and Dominique Nguyen and Blair K Dodson and Gregory J. Seedorf and Steven H Abman},
  booktitle={PloS one},
  year={2016}
}
BACKGROUND AND AIMS Infants with Down syndrome (DS) or Trisomy 21, are at high risk for developing pulmonary arterial hypertension (PAH), but mechanisms that increase susceptibility are poorly understood. Laboratory studies have shown that early disruption of angiogenesis during development impairs vascular and alveolar growth and causes PAH. Human chromosome 21 encodes known anti-angiogenic factors, including collagen18a1 (endostatin, ES), ß-amyloid peptide (BAP) and Down Syndrome Critical… CONTINUE READING
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome

  • WeijermanME, AM van Furth, MD van der Mooren, MM vanWeissenbruch, L Rammeloo, CJ Broers
  • European journal of pediatrics
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…